Latest Tax Credits News

Page 7 of 30
Renegade Exploration has secured an option to acquire the Rooster Hill Monazite Project in Wyoming, tapping into a historically promising rare earth element resource. The move expands Renegade’s US footprint amid rising demand for critical minerals.
Maxwell Dee
Maxwell Dee
18 Dec 2025
Commonwealth Bank of Australia announces a fully franked dividend of AUD 1.1154 per security on its PERLS XIII hybrid notes, scheduled for payment in March 2026.
Victor Sage
Victor Sage
17 Dec 2025
Bendigo and Adelaide Bank has announced a fully franked quarterly dividend of AUD 1.311 per security on its Capital Note BENPH, payable in March 2026. This distribution reflects a steady income stream aligned with the terms set out in the 2020 prospectus.
Victor Sage
Victor Sage
16 Dec 2025
Bank of Queensland Limited has announced a fully franked quarterly distribution of AUD 1.2412 per Capital Note 3 security, payable in March 2026. The distribution reflects a 4.9784% annualised rate based on the BBSW plus a margin.
Victor Sage
Victor Sage
16 Dec 2025
Goodman Group has announced an estimated ordinary dividend of AUD 0.15 per security for the six months ending December 2025, with payment scheduled for February 2026. The dividend is unfranked, and final details will be confirmed in February.
Eva Park
Eva Park
12 Dec 2025
Charter Hall Retail REIT has announced a quarterly unfranked dividend of AUD 0.064 per unit, payable in February 2026, maintaining steady income for investors amid a stable retail property market.
Victor Sage
Victor Sage
11 Dec 2025
Macquarie Group Limited has announced an ordinary dividend of AUD 1.6883 per security for its perpetual capital notes, payable in March 2026. The distribution features a partially franked yield reflecting current market interest rates.
Victor Sage
Victor Sage
11 Dec 2025
ALS Limited has announced a partially franked interim dividend of 19.4 cents per share, payable mid-December, alongside a dividend reinvestment plan priced at $21.97 per share with no discount.
Victor Sage
Victor Sage
8 Dec 2025
Chimeric Therapeutics has won FDA Orphan Drug Designation for its CHM CDH17 CAR-T therapy targeting gastric cancer, advancing its clinical development with regulatory incentives and potential market exclusivity.
Ada Torres
Ada Torres
8 Dec 2025
Terragen Holdings has received nearly $1 million in R&D tax incentives, reinforcing its cash position and fueling ongoing development of its innovative agricultural biotech products.
Ada Torres
Ada Torres
4 Dec 2025
Evolution Trustees Limited announces the final distribution for Seed Financial Income Fund Active ETF (ASX, SFIF) for the period ending 30 November 2025, including key dates and reinvestment plan details.
Claire Turing
Claire Turing
2 Dec 2025
Metcash Limited has announced a fully franked ordinary dividend of AUD 0.085 per share for the half-year ending October 2025, accompanied by a Dividend Reinvestment Plan offering shareholders a choice to reinvest without discount.
Logan Eniac
Logan Eniac
1 Dec 2025